Analyze Diet
The Journal of veterinary medical science2022; 84(10); 1437-1441; doi: 10.1292/jvms.22-0113

Pentosan polysulfate regulates hepcidin expression in native Mongolian horses.

Abstract: The aim of this study was to investigate the anti-hepcidin effect of pentosan polysulfate (PPS) in Mongolian horses. Twenty-six healthy horses were randomly allocated in to two-groups; one group was treated with a PPS once a week for 4-weeks while another group keeping as placebo. Blood samples at day 0 (D0), before race (BR; day 28) and after race (AR; day 28) were analyzed for serum biochemistry, hepcidin and iron concentrations. Significant reduction of hepcidin was observed at AR in PPS group when compared with BR placebo (P<0.05) and AR placebo (P<0.01). Mean hepcidin concentration difference of D0-BR and BR-AR in PPS was greater than the placebo whereas the iron concentration difference is reduced compared to placebo. Results indicate a novel therapeutic application of PPS as an anti-hepcidin compound to control hepcidin in horses while emphasizing further molecular studies.
Publication Date: 2022-08-30 PubMed ID: 36047165PubMed Central: PMC9586020DOI: 10.1292/jvms.22-0113Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Randomized Controlled Trial
  • Veterinary

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explores the effect of pentosan polysulfate on the regulation of hepcidin (a hormone that controls iron absorption) expression in Mongolian horses. Key findings include the potential therapeutic use of this compound to manage hepcidin levels in these animals.

Objective and Methodology

  • The primary goal of this study was to assess the anti-hepcidin effects of a compound known as Pentosan Polysulfate (PPS) in Mongolian horses.
  • The researchers selected 26 healthy horses and divided them randomly into two groups. One group was treated with PPS once a week for four weeks, while the other group was left untreated and served as a control group, referred to as the placebo.
  • Blood samples were collected at key stages – at the start of the study (Day 0), before a race (Day 28), and after the race (Day 28). These samples were then analyzed to determine changes in hepcidin and iron concentrations, as well as general serum biochemistry.

Results

  • The study found a significant reduction in hepcidin levels in the PPS-treated group after the race, compared to both before the race and after the race in the placebo group. The effect was more pronounced compared to after race placebo (with a p value of less than 0.01) than before race placebo (p value less than 0.05).
  • Moreover, the mean difference in hepcidin concentration from Day 0 to before the race and from before the race to after the race in the PPS-treated group was greater than in the placebo group.
  • Interestingly, the difference in iron concentration between these time periods was less in the PPS group compared to the placebo group. This could potentially mean that PPS might be regulating hepcidin expression, subsequently affecting iron levels.

Conclusion

  • This study presents evidence of an innovative therapeutic application for PPS as an anti-hepcidin compound. It demonstrates that PPS can effectively control hepcidin levels in horses, suggesting potential for managing disorders related to iron absorption in these animals.
  • However, the researchers emphasize the need for more detailed molecular studies to understand the underlying mechanisms behind these observations and validate the potential therapeutic use of PPS.

Cite This Article

APA
Wijekoon S, Tsogbadrakh M, Sunaga T, Wang Y, Mwale C, Kim S, Alimaa D, Okumura M. (2022). Pentosan polysulfate regulates hepcidin expression in native Mongolian horses. J Vet Med Sci, 84(10), 1437-1441. https://doi.org/10.1292/jvms.22-0113

Publication

ISSN: 1347-7439
NlmUniqueID: 9105360
Country: Japan
Language: English
Volume: 84
Issue: 10
Pages: 1437-1441

Researcher Affiliations

Wijekoon, Suranji
  • Laboratory of Veterinary Surgery, Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Hokkaido, Japan.
Tsogbadrakh, Mijiddorj
  • Department of Veterinary Surgery and Theriogenology, School of Veterinary Medicine, Mongolian University of Life Science, Ulaanbaatar, Mongolia.
Sunaga, Takafumi
  • Laboratory of Veterinary Surgery, Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Hokkaido, Japan.
Wang, Yanlin
  • Laboratory of Veterinary Surgery, Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Hokkaido, Japan.
Mwale, Carol
  • Laboratory of Veterinary Surgery, Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Hokkaido, Japan.
Kim, Sangho
  • Laboratory of Veterinary Surgery, Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Hokkaido, Japan.
Alimaa, Damdinsuren
  • Department of Veterinary Surgery and Theriogenology, School of Veterinary Medicine, Mongolian University of Life Science, Ulaanbaatar, Mongolia.
Okumura, Masahiro
  • Laboratory of Veterinary Surgery, Department of Veterinary Clinical Sciences, Faculty of Veterinary Medicine, Hokkaido, Japan.

MeSH Terms

  • Animals
  • Horses
  • Iron
  • Pentosan Sulfuric Polyester / pharmacology

References

This article includes 32 references
  1. Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, Taube DH, Bloom SR, Tam FW, Chapman RS, Maxwell PH, Choi P. Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int 75: 976–981.
    doi: 10.1038/ki.2009.21pubmed: 19212416google scholar: lookup
  2. Asperti M, Naggi A, Esposito E, Ruzzenenti P, Di Somma M, Gryzik M, Arosio P, Poli M. High sulfation and a high molecular weight are important for anti-hepcidin activity of heparin. Front Pharmacol 6: 316.
    doi: 10.3389/fphar.2015.00316pmc: PMC4768129pubmed: 26955355google scholar: lookup
  3. Asperti M, Denardo A, Gryzik M, Castagna A, Girelli D, Naggi A, Arosio P, Poli M. Pentosan polysulfate to control hepcidin expression in vitro and in vivo. Biochem Pharmacol 175: 113867.
    doi: 10.1016/j.bcp.2020.113867pubmed: 32088260google scholar: lookup
  4. Bansal MK, Smith MM, Numata Y, Ghosh P. The effects of calcium pentosan polysulfate on inflammatory mediators in the rat air-pouch model of inflammation. Curr Ther Res Clin Exp 54: 714–730.
  5. Beard J, Tobin B. Iron status and exercise. Am J Clin Nutr 72 Suppl: 594S–597S.
    doi: 10.1093/ajcn/72.2.594Spubmed: 10919965google scholar: lookup
  6. Chen B, Li GF, Shen Y, Huang XI, Xu YJ. Reducing iron accumulation: A potential approach for the prevention and treatment of postmenopausal osteoporosis. Exp Ther Med 10: 7–11.
    doi: 10.3892/etm.2015.2484pmc: PMC4486897pubmed: 26170904google scholar: lookup
  7. Collins JF, Wessling-Resnick M, Knutson MD. Hepcidin regulation of iron transport. J Nutr 138: 2284–2288.
    doi: 10.3945/jn.108.096347pmc: PMC2764359pubmed: 18936232google scholar: lookup
  8. Ganz T. Molecular pathogenesis of anemia of chronic disease. Pediatr Blood Cancer 46: 554–557.
    doi: 10.1002/pbc.20656pubmed: 16261603google scholar: lookup
  9. Ghosh P. The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment. Semin Arthritis Rheum 28: 211–267.
    doi: 10.1016/S0049-0172(99)80021-3pubmed: 10073500google scholar: lookup
  10. Ghosh P, Cheras PA. Vascular mechanisms in osteoarthritis. Best Pract Res Clin Rheumatol 15: 693–709.
    doi: 10.1053/berh.2001.0188pubmed: 11812016google scholar: lookup
  11. Ghosh P, Edelman J, March L, Smith M. Effects of pentosan polysulfate in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled pilot study. Curr Ther Res Clin Exp 66: 552–571.
  12. Ghosh P, Smith M, Wells C. Second line agents in osteoarthritis. pp. 363–427. In: Second Line Agents in the Treatment of Rheumatic Diseases (Furst D, Dixon J ed.), Marcel Dekker, New York.
  13. Ghosh P, Wu J, Shimmon S, Zannettino ACW, Gronthos S, Itescu S. Pentosan polysulfate promotes proliferation and chondrogenic differentiation of adult human bone marrow-derived mesenchymal precursor cells. Arthritis Res Ther 12: R28.
    doi: 10.1186/ar2935pmc: PMC2875662pubmed: 20167057google scholar: lookup
  14. Gunay NS, Linhardt RJ. Heparinoids: structure, biological activities and therapeutic applications. Planta Med 65: 301–306.
    doi: 10.1055/s-1999-13990pubmed: 10364832google scholar: lookup
  15. Hinton PS. Iron and the endurance athlete. Appl Physiol Nutr Metab 39: 1012–1018.
    doi: 10.1139/apnm-2014-0147pubmed: 25017111google scholar: lookup
  16. Inoue Y, Matsui A, Asai Y, Aoki F, Matsui T, Yano H. Effect of exercise on iron metabolism in horses. Biol Trace Elem Res 107: 33–42.
    doi: 10.1385/BTER:107:1:033pubmed: 16170220google scholar: lookup
  17. Ma X, Patterson KJ, Gieschen KM, Bodary PF. Are serum hepcidin levels chronically elevated in collegiate female distance runners?. Int J Sport Nutr Exerc Metab 23: 513–521.
    doi: 10.1123/ijsnem.23.5.513pubmed: 23580449google scholar: lookup
  18. McIlwraith CW, Frisbie DD, Kawcak CE. Evaluation of intramuscularly administered sodium pentosan polysulfate for treatment of experimentally induced osteoarthritis in horses. Am J Vet Res 73: 628–633.
    doi: 10.2460/ajvr.73.5.628pubmed: 22533393google scholar: lookup
  19. McKay AKA, Peeling P, Pyne DB, Welvaert M, Tee N, Leckey JJ, Sharma AP, Ross MLR, Garvican-Lewis LA, van Swelm RPL, Laarakkers CM, Burke LM. Acute carbohydrate ingestion does not influence the post-exercise iron-regulatory response in elite keto-adapted race walkers. J Sci Med Sport 22: 635–640.
    doi: 10.1016/j.jsams.2018.12.015pubmed: 30630742google scholar: lookup
  20. Milic R, Martinovic J, Dopsaj M, Dopsaj V. Haematological and iron-related parameters in male and female athletes according to different metabolic energy demands. Eur J Appl Physiol 111: 449–458.
    doi: 10.1007/s00421-010-1656-7pubmed: 20882295google scholar: lookup
  21. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113: 1271–1276.
    doi: 10.1172/JCI200420945pmc: PMC398432pubmed: 15124018google scholar: lookup
  22. Oliveira-Filho JP, Badial PR, Cunha PHJ, Peiró JR, Jr, Araújo JP, Jr, Divers TJ, Winand NJ, Borges AS. Lipopolysaccharide infusion up-regulates hepcidin mRNA expression in equine liver. Innate Immun 18: 438–446.
    doi: 10.1177/1753425911420181pubmed: 21926164google scholar: lookup
  23. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loréal O. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276: 7811–7819.
    doi: 10.1074/jbc.M008923200pubmed: 11113132google scholar: lookup
  24. Scoppetta F, Tartaglia M, Renzone G, Avellini L, Gaiti A, Scaloni A, Chiaradia E. Plasma protein changes in horse after prolonged physical exercise: a proteomic study. J Proteomics 75: 4494–4504.
    doi: 10.1016/j.jprot.2012.04.014pubmed: 22546489google scholar: lookup
  25. Singh B, Arora S, Agrawal P, Gupta SK. Hepcidin: a novel peptide hormone regulating iron metabolism. Clin Chim Acta 412: 823–830.
    doi: 10.1016/j.cca.2011.02.014pubmed: 21333642google scholar: lookup
  26. Smith JT, Schneider AD, Katchko KM, Yun C, Hsu EL. Environmental factors impacting bone-relevant chemokines. Front Endocrinol (Lausanne) 8: 22.
    doi: 10.3389/fendo.2017.00022pmc: PMC5306137pubmed: 28261155google scholar: lookup
  27. Tsogbadrakh M, Sunaga T, Bwalya EC, Wijekoon S, Akaraphutiporn E, Wang Y, Mwale C, Naranbaatar A, Kim S, Hosoya K, Alimaa D, Okumura M. Clinical evaluation of pentosan polysulfate as a chondroprotective substance in native Mongolian horses. Jpn J Vet Res 68: 203–208.
  28. Viatte L, Vaulont S. Hepcidin, the iron watcher. Biochimie 91: 1223–1228.
    doi: 10.1016/j.biochi.2009.06.012pubmed: 19555735google scholar: lookup
  29. Walker BL, Tiong JW, Jefferies WA. Iron metabolism in mammalian cells. Int Rev Cytol 211: 241–278.
    doi: 10.1016/S0074-7696(01)11020-Xpubmed: 11597005google scholar: lookup
  30. Suranji Wijekoon HM, Kim S, Bwalya EC, Fang J, Aoshima K, Hosoya K, Okumura M. Anti-arthritic effect of pentosan polysulfate in rats with collagen-induced arthritis. Res Vet Sci 122: 179–185.
    doi: 10.1016/j.rvsc.2018.11.028pubmed: 30529273google scholar: lookup
  31. Wijekoon S, Sunaga T, Wang Y, Mwale C, Kim S, Okumura M. Pentosan polysulfate regulates hepcidin 1-facilitated formation and function of osteoclast derived from canine bone marrow. PLoS One 17: e0265596.
  32. Zoller H, Vogel W. Iron supplementation in athletes-first do no harm. Nutrition 20: 615–619.
    doi: 10.1016/j.nut.2004.04.006pubmed: 15212743google scholar: lookup

Citations

This article has been cited 2 times.
  1. Satué K, Fazio E, La Fauci D, Medica P. Changes of Hepcidin, Ferritin and Iron Levels in Cycling Purebred Spanish Mares. Animals (Basel) 2023 Mar 31;13(7).
    doi: 10.3390/ani13071229pubmed: 37048485google scholar: lookup
  2. Smith MM, Melrose J. Pentosan Polysulfate Affords Pleotropic Protection to Multiple Cells and Tissues. Pharmaceuticals (Basel) 2023 Mar 13;16(3).
    doi: 10.3390/ph16030437pubmed: 36986536google scholar: lookup